Tonix Pharmaceuticals and Massachusetts General Hospital (MGH) Enter into Research Collaboration on Tonix’s Third Generation anti-CD40-Ligand Monoclonal Antibody, TNX-1500, for the Treatment and Prevention of Kidney Transplant Rejection

CHATHAM, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the signing of a second research
Transplant News by Transplant News

House Passes Smith Bill to Improve Medicare Access: Bill Would Ensure Kidney Transplant Recipients Have Essential Medication Under Medicare | News

This week, the U.S. House of Representatives passed Congressman Jason Smith’s legislation, H.R. 5534, the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Act. This legislation ensures thousands of kidney transplant
Transplant News by Transplant News